Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD
Author:
Affiliation:
1. Department of Dermatology The University of Hong Kong‐Shenzhen Hospital Shenzhen Guangdong China
2. Department of Pathology The University of Hong Kong‐Shenzhen Hospital Shenzhen Guangdong China
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.574
Reference8 articles.
1. Evaluation of clinicopathological and treatment characteristics of 80 patients with acquired perforating dermatosis;Gore Karaali M;Dermatol Ther,2020
2. Clinical practice guide for the treatment of perforating dermatosis;Kawakami T;J Dermatol,2020
3. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology;Tanei R;Geriatr Gerontol Int,2016
4. Atopic dermatitis in the elderly: a review of clinical and pathophysiological hallmarks;Williamson S;Br J Dermatol,2020
5. Up‐regulation of transforming growth factor‐β3 and extracellular matrix proteins in acquired reactive perforating collagenosis;Gambichler T;J Am Acad Dermatol,2009
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation;Frontiers in Immunology;2023-08-10
2. A Case Report and Literature Review of the Role of Dupilumab in the Management of Lichen Planus: Cause or Treatment?;Cureus;2023-07-02
3. Acquired perforating dermatosis successfully treated with dupilumab;JEADV Clinical Practice;2023-05-25
4. Dupilumab in Inflammatory Skin Diseases: A Systematic Review;Biomolecules;2023-03-31
5. Reactive perforating collagenosis treated with dupilumab: A case report and literature review;Dermatologic Therapy;2022-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3